Abstract:Background: The accumulation of advanced glycation end products (AGEs) in body tissue has been implicated in the progression of age-related diseases. Inhibition of AGE formation is the imperative approach for alleviating diabetic complications. Clitoria ternatea extract (CTE) has been demonstrated to possess anti-diabetic activity. However, there is no scientific evidence supporting its anti-glycation activity. The objective of this study was to determine the inhibitory effect of CTE on fructose-induced formation of AGEs and protein oxidation. Antioxidant activity of CTE was also assessed by various methods. Methods: The aqueous extract of CTE (0.25-1.00 mg/ml) was measured for the content of total phenolic compounds, flavonoid, and anthocyanin by Folin-Ciocalteu assay, AlCl3 colorimetric method, and pH differential method, respectively. The various concentrations of CTE were incubated with BSA and fructose at 37°C for 28 days. The formation of fluorescent AGEs, the level of fructosamine, protein carbonyl content, and thiol group were measured. The in vitro antioxidant activity was measured by the 1,1-diphenyl 2-picrylhydrazyl (DPPH) scavenging activity, trolox equivalent antioxidant capacity (TEAC), ferric reducing antioxidant power (FRAP), hydroxyl radical scavenging activity (HRSA), superoxide radical scavenging activity (SRSA), and ferrous ion chelating power (FICP). Results: The results demonstrated that the content of total phenolics, flavonoids and total anthocyanins in CTE was 53 ± 0.34 mg gallic acid equivalents/g dried extract, 11.2 ± 0.33 mg catechin equivalents/g dried extract, and 1.46 ± 0.04 mg cyanidin-3-glucoside equivalents/g dried extract, respectively. Moreover, CTE (0.25-1.00 mg/ml) significantly inhibited the formation of AGEs in a concentration-dependent manner. CTE also markedly reduced the levels of fructosamine and the oxidation of protein by decreasing protein carbonyl content and preventing free thiol depletion. In the DPPH radical scavenging activity and SRSA, CTE had the IC50 values of 0.47 ± 0.01 mg/ml and 0.58 ± 0.04 mg/ml. Furthermore, the FRAP and TEAC values of CTE were 0.38 ± 0.01 mmol FeSO4 equivalents/mg dried extract and 0.17 ± 0.01 mg trolox equivalents/mg dried extract. However, CTE showed weak scavenging activity on hydroxyl radical and a weak antioxidant iron chelator. Conclusions: The results showed that CTE has strong antiglycation and antioxidant properties and might have therapeutic potentials in the prevention of AGE-mediated diabetic complications.

Citral: A Potent Inhibitor of Advanced Glycation End Products

Inhibitory Effects of Hydroxysafflor Yellow A on the Formation of Advanced Glycation End Products in Vitro.

Inhibition of Highland Barley Bran-Derived Carbon Dots on the Formation of Advanced Glycation End Products

Catechin Inhibits the Release of Advanced Glycation End Products During Glycated Bovine Serum Albumin Digestion and Corresponding Mechanisms in Vitro.

Effect of macromolecular crowding on the inhibition of non-enzymatic glycation of bovine serum albumin by cichoric acid

Chlorogenic Acid Inhibits Non-Enzymatic Glycation and Oxidation of Low Density Lipoprotein

Effects of Myricetin and Its Derivatives on Nonenzymatic Glycation: A Mechanism Study Based on Proteomic Modification and Fluorescence Spectroscopy Analysis

Inhibition the Advanced Glycation End Products of Food Natural Antioxidants in Vitro

Inhibition and Mechanism of Protein Nonenzymatic Glycation by Lactobacillus Fermentum

Mechanism Of Isoquercitrin Inhibiting Advanced Glycation Products Formation Based On Fluorescence Spectroscopy Technique

Chitosan inhibits advanced glycation end products formation in chemical models and bakery food

Inhibitory Effect of Artemisia selengensis Straw Flavonoids on the Formation of Advanced Glycation End Products (AGEs)

The inhibition of oleanolic acid on protein non-enzymatic glycation

Cinnamon Bark Proanthocyanidins As Reactive Carbonyl Scavengers to Prevent the Formation of Advanced Glycation Endproducts

Glucitol-core containing gallotannins inhibit the formation of advanced glycation end-products mediated by their antioxidant potential

Inhibitory effects of extracts from Moutan Cortex on formation of advanced glycation end-products (AGEs) in vitro and specificity screening of its potential active components

Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro

[Role and mechanism of Cortex Moutan components in inhibiting production of toxic advanced glycation end products (AGEs)].

Inhibitory effect of epicatechin gallate on protein glycation

Treatment of Proteins with Dietary Polyphenols Lowers the Formation of AGEs and AGE-induced Toxicity.

Beneficial Effects of Cinnamon Proanthocyanidins on the Formation of Specific Advanced Glycation Endproducts and Methylglyoxal-Induced Impairment on Glucose Consumption.